» Articles » PMID: 38613745

Association Between the Social Vulnerability Index and Breast, Cervical, and Colorectal Cancer Screening Rates in Rhode Island

Overview
Specialties Oncology
Public Health
Date 2024 Apr 13
PMID 38613745
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Cancer screening is effective in reducing the burden of breast, cervical, and colorectal cancers, but not all communities have appropriate access to these services. In this study, we aimed to identify under-resourced communities by assessing the association between the Social Vulnerability Index (SVI) with screening rates for breast, cervical, and colorectal cancers in ZIP-code tabulation areas (ZCTAs) in Rhode Island.

Methods: This study leveraged deidentified health insurance claims data from HealthFacts RI, the state's all-payer claims database, to calculate screening rates for breast, cervical, and colorectal cancers using Healthcare Effectiveness Data and Information Set measures. We used spatial autoregressive Tobit models to assess the association between the SVI, its four domains, and its 15 component variables with screening rates in 2019, accounting for spatial dependencies.

Results: In 2019, 73.2, 65.0, and 66.1% of eligible individuals were screened for breast, cervical, and colorectal cancer, respectively. For every 1-unit increase in the SVI, screening rates for breast and colorectal cancer were lower by 0.07% (95% CI 0.01-0.08%) and 0.08% (95% CI 0.02-0.15%), respectively. With higher scores on the SVI's socioeconomic domain, screening rates for all three types of cancers were lower.

Conclusion: The SVI, especially its socioeconomic domain, is a useful tool for identifying areas that are under-served by current efforts to expand access to screening for breast, cervical, and colorectal cancer. These areas should be prioritized for new place-based partnerships that address barriers to screening at the individual and community level.

Citing Articles

Factors Associated With Quality of Life Among Colorectal Cancer Patients: Cross-Sectional Study.

Salazar Florez J, Zapata J, Duarte M, Acevedo V, Calle J, Montoya A Cancer Control. 2024; 31:10732748241302915.

PMID: 39557561 PMC: 11574891. DOI: 10.1177/10732748241302915.

References
1.
Siegel R, Miller K, Wagle N, Jemal A . Cancer statistics, 2023. CA Cancer J Clin. 2023; 73(1):17-48. DOI: 10.3322/caac.21763. View

2.
Weisband Y, Torres L, Paltiel O, Sagy Y, Calderon-Margalit R, Manor O . Socioeconomic Disparity Trends in Cancer Screening Among Women After Introduction of National Quality Indicators. Ann Fam Med. 2021; 19(5):396-404. PMC: 8437575. DOI: 10.1370/afm.2715. View

3.
Tabaac A, Sutter M, Wall C, Baker K . Gender Identity Disparities in Cancer Screening Behaviors. Am J Prev Med. 2018; 54(3):385-393. DOI: 10.1016/j.amepre.2017.11.009. View

4.
Jun J, Nan X . Determinants of Cancer Screening Disparities Among Asian Americans: A Systematic Review of Public Health Surveys. J Cancer Educ. 2017; 33(4):757-768. DOI: 10.1007/s13187-017-1211-x. View

5.
Rutter C, Knudsen A, Lin J, Bouskill K . Black and White Differences in Colorectal Cancer Screening and Screening Outcomes: A Narrative Review. Cancer Epidemiol Biomarkers Prev. 2020; 30(1):3-12. PMC: 7855228. DOI: 10.1158/1055-9965.EPI-19-1537. View